Stable disease and improved health-related quality of life (HRQoL) following fractionated low dose 131I-metaiodobenzyl-guanidine (MIBG) therapy in metastatic paediatric paragan-glioma: observation of false “reverse” discordance during pre-therapy work up and its implication for patient selection for high dose targeted therapy

Basu, SandipNair, Narendra2007-09-262007-09-262006http://hdl.handle.net/123456789/7424789 bytestext/htmlenlow dose131I-metaiodobenzyl-guanidinemetastatic paediatric paragan-gliomaStable disease and improved health-related quality of life (HRQoL) following fractionated low dose 131I-metaiodobenzyl-guanidine (MIBG) therapy in metastatic paediatric paragan-glioma: observation of false “reverse” discordance during pre-therapy work up and its implication for patient selection for high dose targeted therapyArticle